Cited 32 time in
Ferulic acid attenuates focal cerebral ischemia-induced decreases in p70S6 kinase and S6 phosphorylation
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Koh, Phil-Ok | - |
| dc.date.accessioned | 2022-12-27T00:19:58Z | - |
| dc.date.available | 2022-12-27T00:19:58Z | - |
| dc.date.issued | 2013-10-25 | - |
| dc.identifier.issn | 0304-3940 | - |
| dc.identifier.issn | 1872-7972 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/20414 | - |
| dc.description.abstract | Ferulic acid exhibits neuroprotective effects against focal cerebral ischemia. PI3/K and Akt signaling pathways play an essential role in protecting against cerebral ischemia. Mammalian target of rapamycin (mTOR), a major downstream target of Akt, regulates p70S6 kinase and S6, both of which are involved in ribosomal biogenesis and protein synthesis. I investigated whether ferulic acid regulates mTOR, p70S6 kinase, and S6 phosphorylation during brain ischemic injury. Rats were treated immediately with vehicle or ferulic acid (100 mg/kg, i.v.) after middle cerebral artery occlusion (MCAO). Brains tissues were removed at 24 h after the onset of MCAO and the cerebral cortex regions were collected. Ferulic acid reduced the MCAO-induced infarct volume. I showed previously that ferulic acid prevents the MCAO injury-induced decrease of Akt phosphorylation. In this study, MCAO injury induced decreases in mTOR, p70S6 kinase, and S6 phosphorylation levels, while ferulic acid attenuated the injury-induced decreases. Immunohistochemical staining demonstrated that ferulic acid prevented the MCAO-induced reduction in the number of positive cells for phosphorylated p70S6 kinase and phosphorylated S6. These findings suggest that ferulic acid has a neuroprotective function against focal cerebral ischemia by modulating p70S6 kinase expression and S6 phosphorylation. (C) 2013 Elsevier Ireland Ltd. All rights reserved. | - |
| dc.format.extent | 5 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | ELSEVIER IRELAND LTD | - |
| dc.title | Ferulic acid attenuates focal cerebral ischemia-induced decreases in p70S6 kinase and S6 phosphorylation | - |
| dc.type | Article | - |
| dc.publisher.location | 아일랜드 | - |
| dc.identifier.doi | 10.1016/j.neulet.2013.09.001 | - |
| dc.identifier.scopusid | 2-s2.0-84885034037 | - |
| dc.identifier.wosid | 000327825600002 | - |
| dc.identifier.bibliographicCitation | NEUROSCIENCE LETTERS, v.555, pp 7 - 11 | - |
| dc.citation.title | NEUROSCIENCE LETTERS | - |
| dc.citation.volume | 555 | - |
| dc.citation.startPage | 7 | - |
| dc.citation.endPage | 11 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Neurosciences & Neurology | - |
| dc.relation.journalWebOfScienceCategory | Neurosciences | - |
| dc.subject.keywordPlus | PI3 KINASE | - |
| dc.subject.keywordPlus | NEUROPROTECTION | - |
| dc.subject.keywordPlus | APOPTOSIS | - |
| dc.subject.keywordPlus | P70(S6K) | - |
| dc.subject.keywordPlus | SURVIVAL | - |
| dc.subject.keywordPlus | INJURY | - |
| dc.subject.keywordPlus | TARGET | - |
| dc.subject.keywordPlus | AKT | - |
| dc.subject.keywordAuthor | Ferulic acid | - |
| dc.subject.keywordAuthor | Neuroprotection | - |
| dc.subject.keywordAuthor | mTOR | - |
| dc.subject.keywordAuthor | p70S6 kinase | - |
| dc.subject.keywordAuthor | S6 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
